Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...
One in six adults have bladder control problems. It can disrupt sleep or cause accidents, lead to social isolation and depression and affects women more than men.
Jason Whiting, with more than 25 years' experience in medical technology, steps in as CEO of Avation Medical Inc. He succeeds co-founder Jill Schiaparelli, who led the company since 2018, starting ...
Whiting succeeds Jill Schiaparelli, who served in the corner office since 2018. He takes over at the Columbus, Ohio-based non-invasive neuromodulation technology developer advancing a therapy for ...